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Abstract: Cardiomyogenic differentiation from mesenchymal stem cells has emerged as a novel approach for repair of damaged
myocardium. Cell transplantation through direct cell injection is not an optimal method due to the lack of cell–extracellular matrix
interactions. In the present study, differentiation potential of human adipose-derived stem cells (ASCs) to cardiomyocytes has been
investigated by growing them on hyaluronic acid/gelatin (HA/G) plasma gels and coverslips and supplementing the growth medium
with chemical modifiers (activin-a, BMP-4, insulin, valproic acid, and 5-azacytidine) in various combinations. The HA/G plasma gels
were produced from human blood plasma-derived fibrinogen, gelatin, and human umbilical cord-derived hyaluronic acid. A networkbased approach was employed to select marker genes for cardiomyogenic differentiation, and the expression levels of three markers
(GATA4, TBX5, and cTnI) were followed by RT-qPCR to investigate the cardiomyogenic differentiation potential of ASCs. Results
indicated that each combination of chemical modifiers led to different expression levels in the aforementioned cardiac markers, and
this was material-dependent, too. The cardiac gene expression on HA/G plasma gels in the presence of activin-a + BMP-4 or insulin +
valproic acid was more pronounced than in the presence of 5-azacytidine only, and scaffold and chemical modifier combinations were
crucial for cardiomyogenic differentiation.
Key words: Cardiomyogenic differentiation, stem cells, human adipose-derived stem cells, HA/G plasma gel, biomaterials, tissue
engineering

1. Introduction
Heart failure, which is characterized by a gradual loss of
cardiomyocytes, and ischemia, which is characterized
by reduced blood supply to the heart, are major
cardiovascular health problems worldwide (Segers and
Lee, 2008). The increase in morbidity and mortality rates
related to cardiomyocyte loss leads to enhancement of
cellular therapies since donor hearts for transplantation
are in shortage, too. Previous studies on cell replacement
therapies have achieved muscle regeneration and increased
cardiomyocyte numbers in parallel with increased
functionality by preventing hypertrophy at deficient
tissues (Mummery et al., 2010).
Diverse types of stem and progenitor cells have been
shown to improve cardiac function through various
mechanisms, including formation of new endothelial
cells, vascular smooth muscle cells, and myocytes, as
well as through paracrine effects (Vunjak-Novakovic
et al., 2009). In addition, different types of cells such as
* Correspondence: erdal.karaoz@livhospital.com.tr

skeletal myoblasts, bone marrow-derived progenitor
cells, embryonic or neonatal cardiomyocytes, adult
cardiac progenitor cell populations, induced pluripotent
stem cells, reprogrammed somatic cells, and embryonic
stem cells (ESCs) have been investigated as candidates
or models for regenerating damaged cardiomyocytes
(Vunjak-Novakovic et al., 2009).
Adipose is an abundant tissue with a high proportion
of adult stem cells, and these cells can be easily obtained
from the lipoaspirate material. It has been reported that
adipose-derived stem cells (ASCs) have the ability to
differentiate along various mesenchymal lineages in the
presence of induction factors (Zuk et al., 2002). ASCs have
also been shown to be capable of in vitro differentiation
into cardiomyocytes (Rangappa et al., 2003; Planat-Benard
et al., 2004; Palpant and Metzger, 2010). Transplantation of
adipose-derived cardiomyocytes onto an infarcted mouse
heart contributed to cardiac repair (Bai et al., 2010). In cell
transplantation, the major advantage of employing adipose-
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derived cardiomyocytes is the accessibility of the patients’
own adipose by liposuction for autologous transplantation
(Palpant and Metzger, 2010). Treatment with temporal
activin-a and BMP-4 has led to an efficient cardiomyogenic
differentiation from human ESCs (Kattman et al., 2006;
Laflamme et al., 2007). In addition, in vitro treatment
of adult bone marrow cells with 5-azacytidine led to the
expression of cardiomyogenic genes and protein (Makino
et al., 1999). Several studies have reported successful
differentiation of rabbit or mouse ASCs, but not human
ASCs, into contractile cardiomyocyte-like cells (Rangappa
et al., 2003; Strem et al., 2005; Lee et al., 2009). In cardiac
tissue, cardiomyocytes are surrounded by a basement
membrane containing collagen type IV, fibronectin,
laminin, and proteoglycans, and the extracellular space
consists mainly of interstitial collagen types I and III,
with many other macromolecules (Vanwinkle et al.,
1996). In terms of niche, these extracellular matrix (ECM)
components are essential in heart development and in
mechanoelectrical function (Parker and Ingber, 2007). The
high water content of hydrogels creates a tissue-like threedimensional environment (Tibbitt and Anseth, 2009) and
therefore hydrogels are used extensively to mimic ECM.
Hyaluronic
acid
(HA)
is
a
nonsulfated
glycosaminoglycan and is distributed throughout the ECM
of all connective tissues in humans and other mammals
(Yoo et al., 2005). Due to its high biocompatibility and low
immunogenicity, HA is gaining popularity as a biomaterial
for tissue engineering and tissue regeneration (Zheng et
al., 2004; Leach and Schmidt, 2005). Furthermore, HA
is of particular interest due to its ability to promote cell
migration (Yoo et al., 2005).
For the purpose of cell delivery, fibrin glue is an
extensively studied hydrogel system that is formed by
mixing fibrinogen and thrombin via similar mechanisms
involved in normal blood clotting (Christman et al.,
2004; Martens et al., 2009). The major advantage of fibrin
gels over the other gels is that it can be prepared in an
autologous manner. Adipose-derived mesenchymal stem
cells (MSCs) delivered in fibrin gel to treat myocardial
infarction led to increase in arteriole densities and thus to
improved heart function (Zhang et al., 2010).
In the present study, differentiation potential of human
ASCs to cardiomyocytes has been investigated by growing
them on HA/gelatin (HA/G) plasma gels and coverslips.
The HA/G plasma gels were produced from fibrinogen
precipitated from human blood plasma, gelatin, and
human umbilical cord-derived HA and were crosslinked
with glutaraldehyde. ASCs were isolated from human
lipoaspirates and characterized with flow cytometry
at their third passage, and also by differentiation into
osteogenic and adipogenic lineages. The effect of chemical
modifiers, including activin-a, BMP-4, insulin, valproic
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acid, and 5-azacytidine, were also studied by addition
into to the growth medium in various combinations. A
network-based approach was employed to select marker
genes for cardiomyogenic differentiation. To investigate
the cardiomyogenic differentiation potential of ASCs,
the gene expression levels of three marker genes were
examined after 2 and 3 weeks of incubation.
2. Materials and methods
2.1. ASC isolation, expansion, and characterization
ASC isolation from subcutaneous fat of the abdominal
region was performed according to our previous study
(Korurer et al., 2014). The procedures were performed
in accordance with the ethical guidelines of the Kocaeli
University Medical Ethics Committee. Briefly, adipose
tissue was obtained by lipoaspiration material from
female donors; fatty portions were collected with pipette
and digested with 0.1% (w/v) collagenase (GIBCO). Cell
suspension was centrifuged and washed with phosphatebuffered saline (GIBCO). The pellet was resuspended in
basal medium (DMEM/F12; GIBCO) containing 10% fetal
bovine serum (FBS; Invitrogen/GIBCO), 1% L-glutamine,
1 ng/mL bFGF (GIBCO), and 0.1% primocin (InvivoGen)
and then filtered through a strainer (BD Biosciences).
The isolated ASCs were plated in a 25-cm2 tissue culture
flask (BD Biosciences) and were cultured in a humidified
atmosphere of 5% CO2 at 37 °C.
The ASCs were characterized with flow cytometry
at their third passage, and also were differentiated into
osteogenic and adipogenic lineages. Flow cytometry was
performed using FACS Calibur (BD Biosciences). The data
were analyzed with Cell Quest software (BD Biosciences),
and the forward and side scatter profiles were gated out
of debris and dead cells. The surface antigens (CD13,
CD29, CD44, CD90, CD146, CD166, HLA ABC, CD3,
CD8, CD11b, CD14, CD15, CD19, CD33, CD34, CD45,
CD117, and HLA-DR) of the cells were characterized. The
osteogenic and adipogenic differentiation was performed
as described in our previous studies (Karaoz et al., 2010;
Korurer et al., 2014). For in vitro osteogenic differentiation
of ASCs, the osteogenic medium composed of minimum
essential media (MEM; Invitrogen/GIBCO) supplemented
with 10 nM dexamethasone (Sigma-Aldrich), 50 µg/
mL ascorbate-2-phosphate (Wako Chemicals), 10 mM
β-glycerophosphate (Sigma-Aldrich), 0.1% primocin
(InvivoGen), and 10% FBS (Invitrogen/GIBCO) was used.
At the end of the second week, osteogenic differentiation
was assessed by staining with alizarin red (Sigma-Aldrich).
To induce adipogenic differentiation of ASCs, MEM
supplemented with 10% FBS (Invitrogen/GIBCO), 0.5
mM isobutyl-methyl xanthine (IBMX, Sigma-Aldrich),
10–6 M dexamethasone (Sigma-Aldrich), 10 µg/mL insulin
(Invitrogen/GIBCO), 200 µM indomethacin (Sigma-
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Aldrich), and 0.1% primocin (InvivoGen) was added to the
cells during 2 weeks. Intracellular lipid vesicles indicating
adipogenic differentiation were confirmed by Oil Red O
(Sigma-Aldrich) staining.
2.2. Preparation and characterization of HA/G plasma
gels
HA/G plasma gels were prepared and characterized using
the previously described protocol (Korurer et al., 2014).
Briefly, umbilical cord-derived HA and G were crosslinked
using ethyl-3-(3-dimethyl aminopropyl) carbodiimide
hydrochloride/N-hydroxyl succinimide (EDC/NHS).
The final HA:G ratio in the hydrogel was set to 2:98
(w/w). HA/G plasma gel was formed by mixing 120 µL of
concentrated human fibrinogen (480 mg/mL) precipitated
from human blood plasma, 30 µL of crosslinked HA/G
solution, and 30 µL of 40 mM CaCl2 solution in each well
of a 48-well plate. Later, 50 µL of thrombin (40 U/mL)
was added to each well and mixed quickly. The mixture
was stored at 37 °C for 2 h for polymerization and was
crosslinked with glutaraldehyde.
The characterization studies consisted of scanning
electron microscopy (SEM) imaging, compression tests,
porosity and pore size determination of gels, and cell
viability assay on the gels (Korurer et al., 2014). The
morphologies of HA/G plasma gels were observed with
SEM (QUANTA 400F Field Emission). Compression
test of the gels (9.2 mm in diameter) was conducted with
an LR 30 K mechanical tester (Lloyd Instruments). The
gels were stained with Coomassie brilliant blue (Merck)
to determine their porosity and pore size through
microscopy. Gel porosity and pore sizes were determined
from these images taken under a light microscope by
using Scion Image software. The viability, adhesion, and
proliferation rate of ASCs on HA/G plasma gels were
determined by tetrazolium salt, 2-(4-iodophenyl)-3-(4nitrophenyl)-5-(2,4-disulfophenyl)-2H tetrazolium, and
monosodium salt test (WST-1; Roche) for 1, 5, 7, 14, and
21 days (Korurer et al., 2014).
2.3. Cardiomyogenic differentiation of ASCs on the gels
The cardiomyogenic differentiation potential of ASCs on
HA/G plasma gels and coverslips was investigated by using
three different differentiation media (InsuM, Bmp4M, and

5AzaM) and a control medium (ContM) (Table 1). ASCs
were seeded at a density of 7.5 × 103 cells/gel on the HA/G
plasma gels and 7.5 × 103 cell/cm2 on the coverslips in 48well plates. When the cells on the coverslips reached 70%
confluence, chemical modifiers were added to the ASCs
on the gels and coverslips. The media were replaced twice
a week. At the end of the 2nd and 3rd weeks, cell lysis was
performed by applying cell lysis buffer (Roche RNA Isolation Kit) to the cells in each group. Lysed cells were stored
at –80 °C.
2.4. Selection of marker genes for cardiomyogenic
differentiation
A network-based approach was developed to select appropriate marker genes associated with cardiomyogenic
differentiation. Candidate genes were obtained from a
comprehensive literature survey. Protein–protein interaction subnetworks around proteins encoded by candidate
genes were reconstructed using data from a previous study
(Karagoz et al., 2015) and visualized via Cytoscape (Smoot
et al., 2011). The DAVID Functional Annotation Bioinformatics Microarray Analysis tool (Alvord et al., 2007) was
employed to map the granular annotations of genes and
corresponding proteins represented in the subnetworks.
The significantly enriched Gene Ontology (GO) terms
and KEGG pathways were determined by hypergeometric
test, and 0.05 was selected as the P-value threshold. Genes
with significantly enriched GO terms associated with cardiomyogenic differentiation were selected as marker genes
and their expression profiles were followed.
2.5. Gene expression analysis via RT-qPCR
Total RNA was extracted from lysed cells using the High
Pure RNA Isolation Kit (Roche). cDNA was synthesized
using a cDNA synthesis kit (Fermentas). Real-time PCR
was performed under a 2 × 4 × 2 experimental design
with a total of 16 different samples (Table 2) in order to
comparatively analyze the effects of support material (i.e.
HA/G plasma gel or coverslip), the media containing
chemical modifiers (InsuM, Bmp4M, 5AzaM, ContM)
and culture time (14 or 21 days). Cardiac gene expression
was examined through mRNA expression profiles of
selected markers genes, i.e. GATA4, T-box5 (TBX5), and
cardiac troponin I type 3 (cTnI). Primers of these genes

Table 1. Compositions of differentiation and control media employed in the present study.
Medium

Content

InsuM

100 µg/mL insulin (Sigma), 2 mM valproic acid, 10% FBS, 0.1% primocin, L-DMEM

Bmp4M

Activin-a for 24 h and then 10 ng/mL BMP-4, 2 mM valproic acid, 10% FBS, 0.1% primocin, L-DMEM

5AzaM

10 µg/mL 5-azacytidine (Sigma), 10% FBS, 0.1% primocin, L-DMEM for 24 h

ContM

10% FBS, 0.1% primocin, L-DMEM
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Table 2. Experimental design for real-time PCR studies.
Sample ID

Support material

Medium

Culture time (days)

1

HA/G plasma gel

InsuM

14

2

Coverslip

InsuM

14

3

HA/G plasma gel

Bmp4M

14

4

Coverslip

Bmp4M

14

5

HA/G plasma gel

5AzaM

14

6

Coverslip

5AzaM

14

7

HA/G plasma gel

ContM

14

8

Coverslip

ContM

14

9

HA/G plasma gel

InsuM

21

10

Coverslip

InsuM

21

11

HA/G plasma gel

Bmp4M

21

12

Coverslip

Bmp4M

21

13

HA/G plasma gel

5AzaM

21

14

Coverslip

5AzaM

21

15

HA/G plasma gel

ContM

21

16

Coverslip

ContM

21

were designed via Roche Probe Finder software (Table 3).
Primers were diluted with pure water to obtain 20 mM
primer concentration. PCR was performed using optimized
amplification conditions, namely 0.4 µL of reference and
target primers, 0.4 µL of reference and target probe, 3 µL
of pure water, 10 µL of master mix, and 5 µL of cDNA
per single well in a 96-well plate. As housekeeping genes,
10-GUSB, 17-GUSB, and 81-GUSB were used for cTnI,
GATA4, and TBX5, respectively. The real-time PCR assay
was performed using the Dual Color Hydrolysis Probe
with a Roche Light Cycler 450II device. Quantification of

the results was done using the 2–ΔΔCT technique (Livak and
Schmittgen, 2001), which compares the CT values of the
reference and target genes. All real-time PCR experiments
were performed in triplicate (3 independent experiments)
and three trials for each sample were performed (a total of
48 well plates for each experiment).
2.6. Statistical analysis
All experiments were performed in triplicate. Data were
reported as 95% confidence intervals for sample means
(i.e. µ ± 95% CI). In addition, the statistical significance
was analyzed using one-way analysis of variance (ANOVA)

Table 3. Primers for real-time PCR.
Primer
cTnI (NM_000363.4)
GATA4 (NM_002052.3)
TBX5 (NM_000192.3)
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Length (bp)

Position

Tm (°C)

GC (%)

Sequence

Left

21

672–692

59

52

aagaaggaggacaccgagaag

Right

20

718–737

60

50

cagtgcatcgatgttcttgc

Left

20

1513–1532

60

50

ggaagcccaagaacctgaat

Right

19

1592–1610

59

53

gttgctggagttgctggaa

Left

22

609–630

59

50

gaagaggtgggatagttggaga

Right

18

718–735

60

56

ggcaggtcttttgcgtca
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test followed by post-Tukey test. The statistical significance
of same experimental groups depending on the time using
paired sample t-test was applied. Differences between
the experimental and control groups were regarded
as statistically significant when P < 0.05. All statistical
analyses were performed using SPSS 14.0. Statistical
analyses are presented in Supplementary Tables 1 and 2
(on the journal’s website).
3. Results
3.1. Isolation and characterization of human ASCs
The ASCs, which were isolated from human lipoaspirate
material, were attached to the flask surface and
displayed a fibroblast-like spindle-shaped morphology
during their early days of incubation (Figures 1A and
1B). For further characterization, these primary cells
were cultured until 70% confluence, subcultured, and
cryopreserved. Differentiation of ASCs into osteogenic
(Figures 1C and 1D) and adipogenic lineages (Figures 1E
and 1F) were confirmed by immunohistochemical and
immunofluorescence staining. The flow cytometry results
indicated undifferentiated MSC surface antigen profile
(Figure 2).
3.2. Characterization of HA/G plasma gels
Cardiomyogenic differentiation potential of stem cells
may depend on cell niche and the components of the
ECM play a pivotal role in the differentiation process. The
HA/G plasma gels produced in the present study were

9.2 mm in diameter, compact, and easy to handle (Figure
3A). The gels were stained with Coomassie brilliant
blue to determine their porosity and pore sizes, and the
transverse lengths of the pores were measured to get an
idea about the pore sizes of the scaffolds (Figure 3B). The
porosity and average pore diameter of the HA/G plasma
gels were calculated as 71.05 ± 5.39% and 132 ± 19.07 µm,
respectively. Elastic modules of HA/G plasma gels were
calculated as 3.53 ± 0.22 kPa. SEM was used to observe the
porous and fibrous microstructure, surface topography,
and pore size distribution of the scaffolds (Figure 3C)
and the morphology of unseeded (Figure 3D) and ASCseeded HA/G plasma gels after 21 days (Figure 3E). ASCs
metabolized the gel as there was a substantial increase in
pore size on the top portion of the cell seeded gels. ASC
proliferation was determined as a function of time on
coverslips (as a control) and HA/G plasma gels (Figure
3F). Viability, adhesion, and proliferation of cells on these
gels were investigated with respect to time; the amount of
cells on coverslips was much more than that on the gels on
the first day. However, cell numbers on the gels increased
later in culture (P < 0.05).
3.3. Selection of marker genes for cardiomyogenic
differentiation
A network-based approach was employed to select
appropriate marker genes to follow cardiomyogenic
differentiation. Candidate genes, which were commonly
employed in gene expression analysis to follow

Figure 1. Characterization data of ASCs. Morphology of ASCs phase-contrast microscopy, representative flow cytometry analysis
of cell-surface markers on ASCs and staining for differentiations. (A) Passage (P) 0 at day 6. (B) ASCs exhibited large flattened or
fibroblast-like morphology during P2 at day 2. (C, D) Phase-contrast microscopy alizarin red staining control, after osteogenic
differentiation. (E) Phase-contrast microscopy image after 21 days of adipogenic differentiation control. (F) Oil Red O staining
immunofluorescence image after 21 days of adipogenic differentiation. Original magnifications: A: 20×, B: 10×, C: 4×, D: 10×, E:
20×, F: 40×.
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Figure 2. Representative flow cytometry analysis of cell-surface markers on ASCs.

cardiomyogenic differentiation, were obtained from a
comprehensive literature survey (Asumda et al., 2012;
Zhou et al., 2012; Hartung et al., 2013; Pisano et al., 2013).
These included GATA4, Nkx 2.5, Troponin T (cTnT),
a-myosin heavy chain (aMHC), cardiac troponin I (cTnI),
and TBX5. Protein–protein interaction subnetworks
around proteins encoded by candidate genes were
reconstructed and enrichment analysis was employed to
map the granular annotations of genes and corresponding
proteins in the subnetworks. Subnetworks that were
significantly enriched with GO terms directly associated
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with early-phase cardiomyogenic differentiation were
then identified and candidate genes, around which these
subnetworks were reconstructed, were selected as markers
to be employed in RT-qPCR analysis.
When the protein–protein interaction subnetworks
were analyzed, three genes, i.e. GATA4, TBX5, and cTnI,
came into prominence.
Since proteins encoded by GATA4 (Entrez id: 2626)
and TBX5 (Entrez id: 6910) are physically interacting,
their subnetworks were interconnected. According to
enrichment analysis of the integrated subnetwork around

GÖV et al. / Turk J Biol

Figure 3. Characterization studies of HA/G plasma gel. (A) Macrograph of the gel, (B) pore distribution of the gel stained via
Coomassie brilliant blue, (C) SEM micrograph of the HA/G plasma gel on day 1, (D) SEM micrograph of the unseeded HA/G
plasma gel on day 21, (E) SEM micrograph of the cell-seeded HA/G plasma gel on day 21, (F) WST-1 proliferation assay results of
ASCs on HA/G plasma and coverslip.

GATA4 and TBX5, the statistically enriched biological
processes, cellular components, molecular function
terms, and KEGG pathways were all related to embryonic
development of heart. The statistical enrichment of
molecular function terms related to transcription activities
and chromatin binding supported the idea that these genes
are associated with transcription level of cell regulation.
As a result of KEGG pathway enrichment analysis, cancerrelated pathways were also emphasized as significant
pathways related to these genes. At a subnetwork of
genes associated with embryonic development, the
enrichment of cancer pathways is expected since
embryonic processes may cause occurrence of cancer,
because processes occurring during tumorigenesis may
be similar to processes occurring in early development
(Monk and Holding, 2001). According to enrichment
analysis of the subnetwork around cTnI (Entrez id: 7137),
biological processes, cellular components, molecular
function terms, and KEGG pathways were related to the
muscle contraction system process. The enrichment of
structural and functional terms associated with the muscle
contraction process indicated a tendency towards more
specific cardiomyogenic differentiation process.
The statistically significant increase in gene expression
levels of these genes, which are associated with biological
terms related to the embryonic development of heart
and muscle contraction process, could be interpreted

as an indicator for progress towards cardiomyogenic
differentiation of ASCs. Therefore, these three genes were
employed in RT-qPCR analysis as cardiac makers.
3.4. Cardiomyogenic differentiation of ASCs on the gels
After RNA isolation, the amount of RNA of each
experimental group was determined as 10–100 ng/µL.
cDNA was synthesized from RNA and RT-qPCR analyses
were conducted for 16 experimental groups (Table 2).
The comparative expressions of selected cardiac marker
genes were investigated to follow related cardiomyocyte
development. ASCs on coverslips grown in control
medium for 14 and 21 days were used as controls
(sample id: 8 and 16, respectively), and the average CT
value of these controls was used as the reference value.
Comparative analysis using 2–ΔΔCT technique indicated
that differential expression levels were observed for the
investigated genes after 14 and 21 days of culture (Figure 4).
Please see Supplementary Tables 1 and 2 (on the journal’s
website) for further information about the P-values of the
experimental groups.
The expression level of the GATA4 gene was elevated
in all experimental groups at day 21 when compared to
day 14 (Figure 4). The GATA4 gene expression level of
ASCs on the gels was also higher than those cultured on
coverslips for all experimental groups. The maximum
GATA4 gene expression level of ASCs was observed at day
21 on the gels induced with BMP-4 (sample id: 11). The
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Figure 4. Comparative analysis of differential expression levels for GATA4, TBX5, and cTnI genes. All real-time PCR experiments
were performed in triplicate (3 independent experiments). 1: HA/G plasma gel, InsuM, 14 days; 2: coverslip, InsuM, 14 days; 3:
HA/G plasma gel, Bmp4M, 14 days; 4: coverslip, Bmp4M, 14 days; 5: HA/G plasma gel, 5AzaM, 14 days; 6: coverslip, 5AzaM, 14
days; 7: HA/G plasma gel, ContM, 14 days; 8: coverslip, ContM, 14 days; 9: HA/G plasma gel, InsuM, 21 days; 10: coverslip, InsuM,
21 days; 11: HA/G plasma gel, Bmp4M, 21 days; 12: coverslip, Bmp4M, 21 days; 13: HA/G plasma gel, 5AzaM, 21 days; 14: coverslip,
5AzaM, 21 days; 15: HA/G plasma gel, ContM, 21 days; 16: coverslip, ContM, 21 days.

GATA4 expression level of ASCs on the HA/G plasma gels
induced with BMP-4 was 21 times higher when compared
to expression of this gene by the cells on coverslips at day
14 (sample id: 3). However, this ratio increased to 863 at
the end of 21 days (sample id: 11). GATA4 expression level
of ASCs on the gels induced with insulin (sample id: 2)
was 3 times higher than that on the coverslips (sample id:
1) at day 14.
When experimental groups are analyzed in terms
of TBX5 gene expression, the gene expression ratios of
ASCs on the gels were higher than those on the coverslips
(Figure 4). TBX5 expression level of ASCs induced with
BMP-4 medium on the gel (sample id: 11) was less than
that on the coverslip (sample id: 12) at day 21, but this
difference was not statistically significant (P > 0.05). TBX5
expression level of ASCs induced with insulin medium on
the gel (sample id: 9) was highest when compared to the
other experimental groups at day 21.
cTnI expression levels of ASCs induced with BMP-4
and insulin on the gels and coverslips were higher than
the expression levels of other experimental groups and
this expression ratio was significantly increased at day 21
(Figure 4). While cTnI expression level of ASCs on the gels
was higher than that of ASCs on coverslips, this difference
was not statistically significant under insulin induction
(sample id: 9 and 10, respectively) (P > 0.05). On the
other hand, expression level of the cTnI gene was induced
significantly with insulin.
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4. Discussion
Myocardial infarct or myocardial ischemia-like diseases
are associated largely with loss of cells and cardiac tissue
engineering is considered as a feasible approach to
provide a tissue replacement in such cases to ensure the
integrity and regeneration of the damaged tissue. Cardiac
tissue patch is obtained in the laboratory by combining
cardiomyocyte-like cells with a 3D scaffold with an ultimate
aim of providing a functional replacement for the tissue
loss. In cardiac tissue engineering and cardiac regenerative
medicine studies, scaffolds have been produced with
different methods and various different cell types have
been used (Leor et al., 2005; Sterodimas et al., 2010). The
chemical modifiers, mimics of ECM, physical inducers,
and coculture affect the cardiomyogenic differentiation
process of MSCs (Dimarakis et al., 2006). The niche has a
crucial effect on stem cell differentiation and commitment
to self-renewal pathways. Fundamentally, the niche is
the microenvironment of cells and it shapes the behavior
of cells with its structural, biological, and mechanical
features. The target cell differentiation is more efficiently
achieved by provision of both growth factors and various
microenvironmental features to the stem cells in the
laboratory.
In this study, ECM structure was imitated with HA/G
plasma gels and cardiomyogenic differentiation was
investigated under different media supplemented with
several chemical modifiers in different proportions. The
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plasma gels were produced from fibrinogen precipitated
from human blood plasma, gelatin, and human
umbilical cord-derived HA and were crosslinked with
glutaraldehyde. Glutaraldehyde was used to increase the
stability of hydrogels. Considering its induction potential
in in vivo vascularization and repair of damaged heart
tissue (Li and Guan, 2011) as well as human myofibroblast
proliferation and tissue regeneration and/or development
(Ye et al., 2011), fibrinogen was preferred. HA is gaining
popularity as a biomaterial for tissue engineering and
tissue regeneration due to its high biocompatibility and
low immunogenicity (Zheng et al., 2004; Leach et al.,
2015) as well as its ability to promote cell migration (Yoo
et al., 2005). Previously, it has been shown that rate of
cell proliferation and cardiomyogenic differentiation of
C2C12 myoblasts was significantly increased with a film
like scaffold, which was produced by mixing alginate and
gelatin (Rosellini et al., 2009), and films including gelatin
in high proportions were proposed as ideal scaffolds.
Considering the previous findings and gelatin’s effect in
induction of cardiomyogenic differentiation, as well as its
positive effects on cell attachment and expansion, gelatin
concentration in the HA/G plasma gels was kept higher
than the HA concentration in the present study.
The stem cells are considered invaluable as a cell source,
since they are expanded easily in the laboratory and can
be differentiated into many cell types. Nowadays, MSCs
are considered as the most safe stem cells to be used in
medicine. Some MSC types, such as bone marrow-derived,
umbilical cord blood-derived, etc., have been investigated
in preclinical and clinical applications. Through their
secreted growth factors and cytokines, MSCs can decrease
cell death in damaged tissue, accelerate vascularization,
and differentiate into target cells in vivo, and, when they
are used as allogenic cells, even immune rejection can be
suppressed. It has been reported that ASCs have the ability
to differentiate along various mesenchymal lineages in the
presence of induction factors (Zuk et al., 2002). ASCs have
also been shown to be capable of in vitro differentiation
into cardiomyocytes (Rangappa et al., 2003; Planat et al.,
2004; Palpant et al., 2010) and transplantation of adiposederived cardiomyocytes onto an infarcted mouse heart
contributed to cardiac repair (Bai et al., 2010). When
ASCs are transplanted, these cells differentiated into
vascular cells and angiogenesis was improved in damaged
tissue with cardiac factors (Bai et al., 2010). By producing
HA/G plasma gel via the precipitation of fibrinogen from
autologous human plasma, immune reaction probability
may be decreased.
The effects of five chemical modifiers (i.e. activin-a,
BMP-4, insulin, valproic acid, and 5-azacytidine) were
also investigated in this study. Treatment with temporal
activin-a and BMP-4 has led to efficient cardiomyogenic

differentiation from human ESCs with a significant
increase in the percentage of human ESC-derived
cardiomyocytes in the culture from 1% to 30% (Kattman
et al., 2006; Laflamme et al., 2007). In addition, in vitro
treatment of adult bone marrow cells with 5-azacytidine
led to expression of cardiomyogenic genes and proteins
(Wakitani et al., 1995; Makino et al., 1999). Moreover,
the early development of avian pericardial mesoderm
has been found to be regulated by insulin and insulinlike growth factors (Heng et al., 2004). The cardiac
differentiation studies related to use of insulin and valproic
acid were not reported. Since MSCs express genes related
to pluripotency, the protocol (Steven et al., 2008) leading
to efficient cardiomyogenic differentiation of ESCs with
BMP-4 and activin-a was used in this study. 5-Azacytidine,
which leads to cardiomyocyte-like cell production from
MSCs in vitro (Rosca and Burlacu, 2010; Martinez et al.,
2011), was also included in the study.
Several genes have been employed in the determination
of cardiomyogenic differentiation in the literature.
Similar to other biological processes cardiomyogenic
differentiation should also be governed by an organization
of proteins mediated through protein–protein interactions
(Sevimoglu and Arga, 2014). Therefore, a network-based
approach, which considers the interacting partners of a
protein encoded by a candidate gene and their molecular
functions as well as roles in biological processes, was
employed to select appropriate marker genes to follow
cardiomyogenic differentiation in the present study.
Significant enrichment results with biological terms
related to embryonic development of heart and muscle
contraction process were searched. Among the commonly
used genes, three genes, i.e. GATA4, TBX5 and cTnI, came
into prominence as cardiac markers. GATA4 encodes a
member of the GATA family of zinc finger transcription
factors, which regulates genes involved in embryogenesis
and in myocardial differentiation and function (Perrino et
al., 2006). GATA4 is a critical transcription factor for proper
mammalian cardiac development and essential for survival
of the embryo, and it promotes cardiac morphogenesis and
cardiomyocyte survival and maintains cardiac function in
the adult heart (Perrino et al., 2006). T-Box transcription
factor TBX5 is involved in the regulation of developmental
processes. The encoded protein may play a role in heart
development and specification of limb identity (Takeuchi
et al., 2003). Troponin I (TnI), which is a troponin complex,
is a heteromeric protein playing an important role in the
regulation of skeletal and cardiac muscle contraction
(Gomes et al., 2002). The statistically significant increase in
gene expression levels of these genes could be interpreted
as an indicator for progress towards cardiomyogenic
differentiation of ASCs. The GATA4, TBX5, and cTnI gene
expression levels of ASCs on the gels was also higher than
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those cultured on coverslips for all experimental groups.
The cardiomyogenic differentiation level increased with
time. However, GATA4 expression level of ASCs on
the gels induced with insulin (sample id: 2) was 3 times
higher than that on the coverslips (sample id: 1) at day
14. TBX5 expression level of ASCs induced with insulin
medium on the gel (sample id: 9) was the highest when
compared to the other experimental groups at day 21. cTnI
expression levels of ASCs induced with BMP-4 and insulin
on the gels and coverslips were higher than the expression
levels of other experimental groups and this expression
ratio was significantly increased at day 21. Generally,
cardiomyogenic differentiation marker expressions of ASC
were increased in the presence of activin-a and BMP-4 or
insulin- and valproic acid-including medium. As a result
the cardiac gene expression on HA/G plasma gels in the
presence of activin-a and BMP-4 or insulin and valproic
acid was more potent than in the presence of 5-azacytidine
alone.
In conclusion, differentiation potential of human
mesenchymal stem cells to cardiomyocytes was
investigated by growing them simultaneously on gels with

inductions by various chemical modifiers in the present
study. Combination of HA/G plasma gel and growth
factors such as insulin and valproic acid or activin-a
and BMP-4 was assigned for investigations related to
cardiomyogenic differentiation of MSCs. Various chemical
modifiers show different effects on the cardiac marker
gene expressions of ASCs on gels and coverslips, so gene
expression profiles at a broader range must be analyzed
using high-throughput techniques (such as microarrays or
next-generation sequencing) in order to understand and
optimize the differentiation process at the molecular level.
In further studies, it is aimed to increase the percentage
of differentiated cardiomyocytes through scaffold-based
mechanical effects and chemical modifiers. The data
obtained from the present study will be an enlightening
source for in vitro functional 3D heart muscle production
for tissue engineering applications.
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Supplementary Table 1. The statistical significance of experimental groups using one-way analysis of variance (ANOVA)
(gel: HA/G plasma gel, cs: coverslip).
14 days

ContM-cs

ContM-gel

InsuM-cs

InsuM-gel

Bmp4M-cs

Bmp-gel

5AzaM-cs

5AzaM-gel

ContM-gel
InsuM-cs
InsuM-gel
Bmp4M-cs
Bmp4M-gel
5AzaM-cs
5AzaM-gel
ContM-cs
InsuM-cs
InsuM-gel
Bmp4M-cs
Bmp4M-gel
5AzaM-cs
5AzaM-gel
ContM-cs
ContM-gel
InsuM-gel
Bmp4M-cs
Bmp4M-gel
5AzaM-cs
5AzaM-gel
ContM-cs
ContM-gel
InsuM-cs
Bmp4M-cs
Bmp4M-gel
5AzaM-cs
5AzaM-gel
ContM-cs
ContM-gel
InsuM-cs
InsuM-gel
Bmp4M-gel
5AzaM-cs
5AzaM-gel
ContM-cs
ContM-gel
InsuM-cs
InsuM-gel
Bmp4M-gel
5AzaM-cs
5AzaM-gel
ContM-cs
ContM-gel
InsuM-cs
InsuM-gel
Bmp4M-cs
Bmp4M-gel
5AzaM-gel
ContM-cs
ContM-gel
InsuM-cs
InsuM-gel
Bmp4M-cs
Bmp4M-gel
5AzaM-cs

21 days

GATA4
P-values

TBX5
P-values

cTNI
P-values

GATA4
P-values

TBX5
P-values

cTNI
P-values

0.000
1.000
0.008
0.000
0.103
0.999
0.540
0.000
0.000
0.033
1.000
0.003
0.000
0.000
1.000
0.000
0.020
0.000
0.214
0.977
0.789
0.008
0.033
0.020
0.082
0.879
0.003
0.289
0.000
1.000
0.000
0.082
0.007
0.000
0.001
0.103
0.003
0.214
0.879
0.007
0.041
0.944
0.999
0.000
0.977
0.003
0.000
0.041
0.282
0.540
0.000
0.789
0.289
0.001
0.944
0.282

0.332
1.000
0.212
0.201
0.000
0.521
1.000
0.332
0.330
0.003
0.003
0.000
1.000
0.445
1.000
0.330
0.214
0.203
0.000
0.518
1.000
0.212
0.003
0.214
1.000
0.000
0.005
0.147
0.201
0.003
0.203
1.000
0.000
0.005
0.139
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.521
1.000
0.518
0.005
0.005
0.000
0.653
1.000
0.445
1.000
0.147
0.139
0.000
0.653

0.007
0.000
0.000
0.000
0.000
1.000
0.233
0.007
0.000
0.000
0.001
0.000
0.010
0.561
0.000
0.000
0.000
0.000
0.007
0.000
0.000
0.000
0.000
0.000
0.000
0.515
0.000
0.000
0.000
0.001
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.007
0.515
0.000
0.000
0.000
0.233
0.561
0.000
0.000
0.000
0.000
0.307
0.999
0.000
0.977
0.003
0.000
0.041
0.282

0.000
1.000
0.008
0.000
0.103
0.540
0.999
0.000
0.000
0.033
1.000
0.003
0.000
0.000
1.000
0.000
0.020
0.000
0.214
0.789
0.977
0.008
0.033
0.020
0.082
0.879
0.289
0.003
0.000
1.000
0.000
0.082
0.007
0.001
0.000
0.103
0.003
0.214
0.879
0.007
0.944
0.041
0.999
0.000
0.977
0.003
0.000
0.041
0.282
0.540
0.000
0.789
0.289
0.001
0.944
0.282

0.001
0.083
0.000
0.000
0.009
0.990
0.004
0.001
0.383
0.000
0.540
0.953
0.000
0.996
0.083
0.383
0.000
0.013
0.934
0.018
0.771
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.540
0.013
0.000
0.110
0.000
0.214
0.009
0.953
0.934
0.000
0.110
0.002
1.000
0.990
0.000
0.018
0.000
0.000
0.002
0.001
0.004
0.996
0.771
0.000
0.214
1.000
0.001

1.000
0.000
0.000
0.000
0.000
1.000
1.000
1.000
0.000
0.000
0.000
0.000
1.000
0.997
0.000
0.000
0.887
0.023
0.987
0.000
0.000
0.000
0.000
0.887
0.234
1.000
0.000
0.000
0.000
0.000
0.023
0.234
0.110
0.000
0.000
0.000
0.000
0.987
1.000
0.110
0.000
0.000
1.000
1.000
0.000
0.000
0.000
0.000
1.000
1.000
0.997
0.000
0.000
0.000
0.000
1.000
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Supplementary Table 2. The statistical significance of same experimental
groups depending on time using paired sample t-test (gel: HA/G plasma gel, cs:
coverslip, 14: 14 days, 21: 21 days).
GATA4
P-values

TBX5
P-values

cTNI
P-values

ContM-cs-14 – ContM-cs-21

0.000

0.009

0.075

ContM-gel-14 – ContM-gel-21

0.019

0.034

0.170

InsuM-cs-14 – InsuM-cs-21

0.060

0.211

0.025

InsuM-gel-14 – InsuM-gel-21

0.098

0.015

0.009

Bmp4M-cs-14 – Bmp4M-cs-21

0.074

0.305

0.000

Bmp4M-gel-14 – Bmp4M-gel-21

0.021

0.002

0.063

5AzaM-cs-14 – 5AzaM-cs-21

0.000

0.004

0.001

5AzaM-gel-14 – 5AzaM-gel-21

0.009

0.307

0.018

Compared groups

2

